Tackling Pharmacokinetic and Pharmacodynamic Challenges in Antifungal Therapy

Fungal infections cause substantial morbidity and mortality globally. While antifungal resistance is on the rise, the current antifungal treatment options include a limited number of therapeutic classes which have many pharmacokinetic (PK) and pharmacodynamic (PD) challenges. This webinar will host a expert discussions of recent advances to overcome PK and PD challenges for antifungal treatment.

– Presentation 1: Overcoming PK/PD issues with azoles: A fosravuconazole case study (Wendy (Wan-Yu) Chu)
– Presentation 2: The distinct pharmacokinetic profile of rezafungin (Francelise Bridi Cavassin)
– Presentation 3: Pharmacology of new antifungals (David Andes)

This webinar is done in collaboration with the Centers for Disease Control and Prevention U.S. CDC and will be broadcast during Fungal Awarness Week.